Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Journal of Human Lactation : Official Journal of International Lactation Consultant Association|February 10, 2006
Biochemical analysis of human milk treated with sodium dodecyl sulfate, an alkyl sulfate microbicide that inactivates human immunodeficiency virus type 1Sandra Urdaneta Hartmann, Brian Wigdahl, Elizabeth B Neely, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2002
Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfateFred C Krebs, Shendra R Miller, Bradley J Catalone, et al.
Vaccine|April 18, 2014
In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccineDivya Sagar, Shet Masih, Todd Schell, et al.
Current HIV Research|March 25, 2016
HIV-1 Latency and Eradication: Past, Present and FuturePrasun K Datta, Rafal Kaminski, Wenhui Hu, et al.
Ebiomedicine|January 24, 2024
Host glycosylation of immunoglobulins impairs the immune response to acute Lyme diseaseBenjamin S Haslund-Gourley, Jintong Hou, Kyra Woloszczuk, et al.
Biomedicines|January 21, 2023
Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific ImmunotherapyHager Mohamed, Rachel Berman, Jennifer Connors, et al.
American Journal of Infectious Diseases|March 6, 2010
Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatients at a Community Care CenterNirmala Rajagopalan, Joyce B Suchitra, Anita Shet, et al.
Frontiers in Genome Editing|October 29, 2021
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 TherapyAndrew Atkins, Cheng-Han Chung, Alexander G Allen, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2008
Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infectionNina Thakkar, Vanessa Pirrone, Shendra Passic, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infectionNina Thakkar, Vanessa Pirrone, Shendra Passic, et al.
Pageof 16